1. Home
  2. GTY vs OGN Comparison

GTY vs OGN Comparison

Compare GTY & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$29.83

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.09

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTY
OGN
Founded
1955
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTY
OGN
Price
$29.83
$8.09
Analyst Decision
Buy
Hold
Analyst Count
4
5
Target Price
$31.25
$14.10
AVG Volume (30 Days)
465.8K
6.9M
Earning Date
02-11-2026
02-12-2026
Dividend Yield
6.54%
0.98%
EPS Growth
10.25
N/A
EPS
1.28
1.91
Revenue
$214,194,000.00
$6,301,000,000.00
Revenue This Year
$6.51
N/A
Revenue Next Year
$9.79
N/A
P/E Ratio
$23.21
$4.29
Revenue Growth
8.17
N/A
52 Week Low
$25.39
$6.18
52 Week High
$32.17
$17.23

Technical Indicators

Market Signals
Indicator
GTY
OGN
Relative Strength Index (RSI) 59.76 43.82
Support Level $28.72 $8.17
Resistance Level $30.02 $8.53
Average True Range (ATR) 0.50 0.44
MACD 0.01 -0.15
Stochastic Oscillator 68.75 5.12

Price Performance

Historical Comparison
GTY
OGN

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: